Cannon Gillian 4
4 · CORCEPT THERAPEUTICS INC · Filed Sep 8, 2025
Insider Transaction Report
Form 4
Cannon Gillian
Director
Transactions
- Exercise/Conversion
Stock option (right to buy)
2025-09-04−11,000→ 49,000 totalExercise: $22.99Exp: 2030-12-01→ Common Stock (11,000 underlying) - Exercise/Conversion
Common Stock
2025-09-04$22.99/sh+11,000$252,890→ 11,000 total - Tax Payment
Common Stock
2025-09-04$70.13/sh−3,607$252,959→ 7,393 total
Footnotes (2)
- [F1]These shares were withheld so the Reporting Person could satisfy the exercise price from a net (cashless) exercise of options.
- [F2]Fully exercisable.